Fundraising Fox

ZAGENO

Cambridge, US · Founded 2015 · Delaware corporation · 7 known investors

Find your way into ZAGENO

670 people in our graph share verified history with the ZAGENO team — schools, employers, funds. One of them is your warm intro.

David Phuunlockedknows David Pumberger · together at PwC Management Consulting (overlapped)
×11knows the team · via PwC Management Consulting

Founders & leadership

ZAGENO was founded in 2015 by Florian Wegener and David Pumberger.

FWFlorian Wegener
Florian WegenerinCo-founder
DPDavid Pumberger
David PumbergerinCo-founderDavid Pumberger is an entrepreneur building ZAGENO, a digital marketplace for life sciences researchers.
KV
Kilian VeerNamed on SEC filing

Board

ARAlec Rauschenbusch
Alec RauschenbuschinBoard directorFounder and Managing Director at Grazia Equity GmbH
LBLarry Bohn
Larry Bohnin𝕏Board directorInvestment Team at General Catalyst
JV
Josef Von RickenbachBoard director

Investors · 7

Caesar VenturesMunich
CapnamicCologne · $540K – $3.2M
Grazia Equity GmbHStuttgart · $540K – $2.7M
General Catalystreported · 3 sourcesSan Francisco · $30M

Also in the syndicate · 3

Capnamic VenturesHighSage VenturesOakRidge Management Grouplead

Reported raises · per SEC filings

Form D private placements

$15.9M disclosed across 2 of 4 rounds · 2017–2025

▶$8MraisedAug 2025 · 7 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alec RauschenbuschDirector
  • Florian WegenerExecutive Officer, Director, Promoter
  • David PumbergerExecutive Officer, Director, Promoter
  • Larry BohnDirector
  • Josef Von RickenbachDirector
Offering amount
$12M
Amount sold
$8M
First sale
Aug 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.9MraisedJul 2017 · 11 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alec RauschenbuschDirector
  • Kilian VeerExecutive Officer, Director, Promoter
  • David PumbergerExecutive Officer, Director, Promoter
  • Florian WegenerExecutive Officer, Director, Promoter
Offering amount
$8.2M
Amount sold
$7.9M
First sale
Jul 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Agilent71 shared keywordsAgilent manufactures laboratory instruments, software, reagents, and consumables for pharmaceutical, diagnostics, clinical research, and applied markets including chemicals, food, and environmental sectors. The company operates through three segments: Life Sciences and Diagnostics Markets (which includes contract manufacturing services for oligonucleotide therapeutics and pathology solutions), Agilent CrossLab (providing lab services and automation), and Applied Markets (offering analytical instruments and software).

Companies competing with ZAGENO for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Trysignalbasetrysignalbase.com · Jul 2026How to Conduct Market Research for Your Biotech Startup | Blog | ZAGENOgo.zageno.com · Feb 2025ZAGENO Secures $33M Funding to Revolutionize Life Science Research Procurementfinance.yahoo.com · May 2023ZAGENO Will Champion Researchers Through $60 Million in New Financing Led by General Catalyst and a Large, Vertically Integrated, Nonprofit Healthcare Organizationglobenewswire.com · Nov 2021

Frequently asked questions

Who founded ZAGENO?
ZAGENO was founded by Florian Wegener, David Pumberger in 2015.
Who are ZAGENO's investors?
ZAGENO's investors include Caesar Ventures, Capnamic, Grazia Equity GmbH, General Catalyst.
How much funding has ZAGENO raised?
ZAGENO has disclosed $15.9M raised across 2 of its 4 known rounds.
Where is ZAGENO headquartered?
ZAGENO is headquartered in Cambridge, US.